Stock Track | Progyny Plummets 11.21% Intraday on Disappointing Guidance, Client Loss and Slowing Growth

Stock Track

02/27

Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.

The sharp drop comes after the company issued financial guidance that fell short of analyst expectations. Progyny's outlook for the first quarter of 2026 and its adjusted earnings per share guidance for the full year 2026 were both below market expectations, triggering negative investor sentiment.

Further pressure stemmed from the company's projection of slower revenue growth for fiscal year 2026, estimated between 5.1% and 9%, which represents a deceleration from the 10% growth achieved in 2025. The first-quarter 2026 revenue growth guidance of just 2.5% was particularly disappointing to analysts. The company also confirmed the loss of a large client that did not renew its contract, and reported a 1.1% revenue decline in its pharmacy benefit services segment during the latest quarter.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1176700835"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176700835\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176700835?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 22:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176700835","market":"hk","top_or_hot":-1,"title":"Stock Track | Progyny Plummets 11.21% Intraday on Disappointing Guidance, Client Loss and Slowing Growth","media":"Stock Track","content":"<p>Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.</p><p>The sharp drop comes after the company issued financial guidance that fell short of analyst expectations. Progyny's outlook for the first quarter of 2026 and its adjusted earnings per share guidance for the full year 2026 were both below market expectations, triggering negative investor sentiment.</p><p>Further pressure stemmed from the company's projection of slower revenue growth for fiscal year 2026, estimated between 5.1% and 9%, which represents a deceleration from the 10% growth achieved in 2025. The first-quarter 2026 revenue growth guidance of just 2.5% was particularly disappointing to analysts. The company also confirmed the loss of a large client that did not renew its contract, and reported a 1.1% revenue decline in its pharmacy benefit services segment during the latest quarter.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Progyny Plummets 11.21% Intraday on Disappointing Guidance, Client Loss and Slowing Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Progyny Plummets 11.21% Intraday on Disappointing Guidance, Client Loss and Slowing Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-27 22:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.</p><p>The sharp drop comes after the company issued financial guidance that fell short of analyst expectations. Progyny's outlook for the first quarter of 2026 and its adjusted earnings per share guidance for the full year 2026 were both below market expectations, triggering negative investor sentiment.</p><p>Further pressure stemmed from the company's projection of slower revenue growth for fiscal year 2026, estimated between 5.1% and 9%, which represents a deceleration from the 10% growth achieved in 2025. The first-quarter 2026 revenue growth guidance of just 2.5% was particularly disappointing to analysts. The company also confirmed the loss of a large client that did not renew its contract, and reported a 1.1% revenue decline in its pharmacy benefit services segment during the latest quarter.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PGNY","symbol_name":"Progyny","start_time":0,"source_url":"","article_id":"1176700835","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176700835","pubTimestamp":1772203003,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.The sharp drop comes after the company issued financial guidance that...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PGNY":"Progyny"},"translate_title":"个股追踪|Progyny盘中暴跌11.21%，因指引令人失望、客户流失和增长放缓","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PGNY":1},"content_text":"Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.The sharp drop comes after the company issued financial guidance that fell short of analyst expectations. Progyny's outlook for the first quarter of 2026 and its adjusted earnings per share guidance for the full year 2026 were both below market expectations, triggering negative investor sentiment.Further pressure stemmed from the company's projection of slower revenue growth for fiscal year 2026, estimated between 5.1% and 9%, which represents a deceleration from the 10% growth achieved in 2025. The first-quarter 2026 revenue growth guidance of just 2.5% was particularly disappointing to analysts. The company also confirmed the loss of a large client that did not renew its contract, and reported a 1.1% revenue decline in its pharmacy benefit services segment during the latest quarter.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}